Table 2b Distribution of fibrosis grades stratified according to liver disease etiology (n=311)

From: The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis

Liver disease etiology; % ( n)

F0-1

F2

F3

F4

NAFLD

62.0 (93)

13.3 (20)

11.3 (17)

13.3 (20)

Viral hepatitis

36.0 (31)

26.7 (23)

12.8 (11)

24.4 (21)

AIH/CLD/Overlap

18.6 (8)

46.5 (20)

9.3 (4)

25.6 (11)

DILI

87.5 (7)

12.5 (1)

0.0 (0)

0.0 (0)

ALD

0.0 (0)

10.0 (1)

0.0 (0)

90.0 (9)

Cryptogenic

77.8 (7)

0.0 (0)

0.0 (0)

22.2 (2)